A 68-year-old male with a new diagnosis of heart failure with reduced ejection fraction (HFrEF) is being evaluated for initiation of guideline-directed medical therapy (GDMT). His vital signs are stable, and he is euvolemic. According to the 2024 ACC Expert Consensus Decision Pathway, which of the following represents the core foundational therapies that should be initiated?